Bispecific Molecule Stabilizing Composition
Application
US20260083841A1
Kind: A1
Mar 26, 2026
Inventors
Wei Qi, Cindy Ren
Abstract
The present invention provides provide a pharmaceutical composition comprising a bispecific antigen binding molecule at an increased concentration, wherein the composition comprises at least one buffer agent, at least one saccharide; and at least one stabilizing agent selected from Ethylenediaminetetraacetic acid (EDTA), Diethylenetriaminepentetic acid (DTP A), and citric acid in order to stabilize the bispecific antigen-binding agent even at higher concentration.
CPC Classifications
A61K 39/39591
A61K 47/183
A61K 47/26
A61K 47/40
C07K 16/28
C07K 16/2803
C07K 16/2809
C07K 16/2878
C07K 16/3092
C07K 2317/31
C07K 2317/94
Filing Date
2023-09-14
Application No.
19109730